Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Alexandrosz Czira, Shoko Akiyama, Takeo Ishii, Robert P Wood, Lucinda J Camidge, Hannah Wallis, Thomas Jennison, Rosie AC Wild, Masao Yarita, Kenichi Hashimoto, Kieran J Rothnie & Afisi S Ismaila. (2023) Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A Retrospective Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2933-2953.
Read now
Read now
Héctor E. Alcalá, Amanda E. Ng, Nicholas Tkach & Zoha Salam. (2023) Adverse Childhood Experiences and Utilization and forgoing of Health Care among Children: A Nationally Representative Study in the United States. Children's Health Care 52:3, pages 321-336.
Read now
Read now
Alfredo Chetta, Nicola Facciolongo, Cosimo Franco, Laura Franzini, Alessio Piraino & Carmelina Rossi. (2022) Impulse Oscillometry, Small Airways Disease, and Extra-Fine Formulations in Asthma and Chronic Obstructive Pulmonary Disease: Windows for New Opportunities. Therapeutics and Clinical Risk Management 18, pages 965-979.
Read now
Read now
Joseph Tkacz, Kristin A Evans, Daniel R Touchette, Edward Portillo, Charlie Strange, Anthony Staresinic, Norbert Feigler, Sushma Patel & Michael Pollack. (2022) PRIMUS – Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD Exacerbation. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 329-342.
Read now
Read now
David Mannino, Michael Bogart, Guillaume Germain, Shirley P Huang, Afisi S Ismaila, François Laliberté, Young Jung, Sean D MacKnight, Marjorie A Stiegler & Mei Sheng Duh. (2022) Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 491-504.
Read now
Read now
Leah B Sansbury, Robert P Wood, Glenn A Anley, Yein Nam & Afisi S Ismaila. (2021) Quantifying the Economic Impact of Delayed Multiple-Inhaler Triple Therapy Initiation in Patients with COPD: A Retrospective Cohort Study of Linked Electronic Medical Record and Hospital Administrative Data in England. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2795-2808.
Read now
Read now
Antoni Sicras-Mainar, Francisco J de Abajo & José Luis Izquierdo-Alonso. (2020) Clinical and Economic Consequences of Inhaled Corticosteroid Doses and Particle Size in Triple Inhalation Therapy for COPD: Real-Life Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3291-3302.
Read now
Read now
Articles from other publishers (3)
Kristin A EvansMichael PollackEdward PortilloCharlie StrangeDaniel R TouchetteAnthony StaresinicSushma PatelJoseph TkaczNorbert Feigler. (2022) Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study. Journal of Managed Care & Specialty Pharmacy 28:12, pages 1366-1377.
Crossref
Crossref
Chang-Hoon Lee, Mi-Sook Kim, See-Hwee Yeo, Chin-Kook Rhee, Heung-Woo Park, Bo-Ram Yang, Joongyub Lee, Eun-Yeong Cho, Xiaomeng Xu, Aldo Amador Navarro Rojas, Sumitra Shantakumar, Dominique Milea & Nam-Kyong Choi. (2022) Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea. Respiratory Research 23:1.
Crossref
Crossref
Antoni Sicras-Mainar, Rocío Aller, Javier Crespo Garcia, José Luis Calleja, Juan Turnes, Manuel Romero-Gómez & Salvador Augustín. (2020) Overall clinical and economic impact of non-alcoholic fatty liver disease. Revista Española de Enfermedades Digestivas.
Crossref
Crossref